Israeli startup Kadimastem to merge With NLS Pharmaceutics

Feb 02, 2025

Shareholders of the Israeli bio-pharmaceutical startup, Kadimastem Ltd. approved the company's merger with the Swiss bio-pharmaceutical company NLS Limited on Thursday.